Navigation Links
Families of Spinal Muscular Atrophy; University of California, Irvine Stem Cell Scientist; and California Stem Cell Announce Collaboration for Safety Studies for Stem Cell Therapy in Spinal Muscular Atrophy

Safety Studies Leading to FDA Application for Stem Cell Therapy in SMA will begin in early 2008

LIBERTYVILLE, Ill., Feb. 19 /PRNewswire-USNewswire/ -- Families of Spinal Muscular Atrophy (FSMA); a stem cell scientist at University of California, Irvine (UCI); and California Stem Cell, Inc. (CSC) are pleased to announce a partnership to advance a potential stem cell therapy for SMA to human clinical trials. The specific set of animal studies planned, which will be conducted in accordance with FDA regulations, will assess the safety of motor neuron progenitors derived from human stem cells after transplantation.

SMA is a genetic disorder with no current treatment that is the leading genetic killer of children younger than two years of age. SMA typically is marked by the degeneration of voluntary muscle movement including the muscles that control crawling, walking, swallowing or breathing due to the dysfunction or death of motor neurons. It is a debilitating and often fatal disease.

These safety studies are the critical steps in advancing stem cell therapy into human trials for SMA. High purity human motor neuron populations for use in transplant therapies were developed by CSC and have been used successfully in proof of concept efficacy and preliminary safety studies in the laboratory of Dr. Hans Keirstead at UCI with funding from FSMA. CSC employs scalable manufacturing protocols to produce and supply the large population of clinical-grade motor neuron progenitors required for these pivotal studies and future human clinical trials.

"This collaboration illustrates the breadth of skills that are required to take a potential treatment from the bench to the bedside. I am confident that we have assembled the right team and the right plan to move this treatment forward with both diligence and speed," said Hans S. Keirstead, Professor, UCI.

"California Stem Cell is very pleased to be part of this collaboration with Families of SMA and UCI and optimistic, based on preliminary data, about the very real potential for success in developing a cell transplant therapy for SMA, which devastates so many families." said Chris Airriess, Chief Operating Officer, CSC.

Studies are being conducted in parallel at both the Keirstead laboratory at UCI and the laboratory of Dr. Douglas Kerr at Johns Hopkins University, with funding from FSMA, to show the benefit of human motor neuron progenitor replacement in animal models of motor neuron disease. This builds on the pioneering work published by Dr. Kerr in the Annals of Neurology in 2005 showing that transplants of mouse embryonic stem cell-derived motor neurons into the spinal cord can connect with muscles and partially restore function in paralyzed rats.

"This program holds a tremendous amount of promise for our patients and families. While FSMA makes significant investments in traditional and relatively low-risk drug approaches to find a treatment for SMA, alternative therapies like stem cells may hold the key to a cure. Our strategy is to fund both approaches in parallel to reach our goals as quickly as possible while minimizing risks" said Kenneth Hobby, Executive Director, FSMA. "Families of SMA is extremely grateful to The Dhont Family Foundation for the support of $200,000 given to help move this stem cell program forward."

Stem cell therapy for SMA has the potential to replace the motor neurons lost during the disease course. While other types of therapies have the potential to slow disease progression and possibly increase strength, motor neuron replacement through the use of stem cells is the only means to replace motor neurons once they are gone.

This strategy may be useful for treating multiple disorders such as spinal cord injury, transverse myelitis, and Amyotrophic Lateral Sclerosis (ALS) in addition to Spinal Muscular Atrophy.

About Families of Spinal Muscular Atrophy:

Families of SMA is dedicated to developing a treatment and cure for SMA by promoting and supporting research, helping families cope through informational programs and support, and educating the public and the medical community about SMA. The organization, originally founded in 1984 by a small group of parents, has grown to more than 32 chapters and affiliates worldwide and more than 50,000 supporters. FSMA receives the majority of its revenues through volunteer efforts, funding almost $40 million to date for research. FSMA-sponsored research has made significant contributions to better understanding SMA and advancing new therapies towards human clinical testing. See for more information. Media contact: or call 800 886-1762.

About California Stem Cell, Inc:

Irvine, CA based California Stem Cell, Inc is a privately held company focused on the manufacturing of high purity human cells for therapeutic development and clinical application. Founded in 2005, CSC has developed proprietary methods for scalable production of human motor neurons, neuronal progenitors, cardiac muscle and sino-atrial node cells. Media contact:

About the University of California, Irvine:

The University of California, Irvine is a top-ranked university dedicated to research, scholarship and community service. Founded in 1965, UCI is among the fastest-growing University of California campuses, with more than 27,000 undergraduate and graduate students, and nearly 2,000 faculty members. The third-largest employer in dynamic Orange County, UCI contributes an annual economic impact of $3.6 billion. For more UCI news, visit

SOURCE Families of Spinal Muscular Atrophy
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Ranier Technology Secures GBP8m Funding for its Cadisc Replacement Spinal Discs
2. Insmed Awarded $2.1 Million by Muscular Dystrophy Association
3. Kiwa Bio-Tech Products Group Discusses Cooperative Research With the University of Waterloo, Canada
4. Medical University of South Carolina Opens State-of-the-Art Facility
5. Montana State University lab gives early warnings about biological invaders
6. University of Maryland, Baltimore BioPark Signs Gliknik Inc. as First Tenant in Its BioInnovation Center in Building Two
7. Research by Case Western Reserve University, VA earns cover of prestigious science publication
8. Arizona Pain Society and Dr. Robert Barkin, Rush University Medical Center, Present Program on Comprehensive Urine Drug Testing Sponsored by Dominion Diagnostics
9. Masada Resource Group Donates TVA Biomass Pilot Plant Facilities and Equipment to Auburn University
10. Rosetta Genomics and Columbia University Medical Center to Develop MicroRNA-based Diagnostics for Leukemia and Non Hodgkin Lymphoma
11. Cardiff University engineers give industry a moths eye view
Post Your Comments:
(Date:10/8/2015)... /PRNewswire/ - RepliCel Life Sciences Inc. (OTCQB: REPCF) (TSX.V: RP), ... development of autologous cell therapies, today announced its schedule of ... in the month of October: Stem Cell ... will be presenting at the annual Partnering Forum, part ... be held October 7-9 in La Jolla, ...
(Date:10/8/2015)... ... October 08, 2015 , ... Cystic fibrosis (CF) is ... (CFTR) gene and results in dysfunction of the lungs and the gastrointestinal (GI) ... This mucus is very difficult to clear, blocks the airways and the glands, ...
(Date:10/7/2015)...  ChromaDex Corp. (OTCQX: CDXC), an innovator of ... science-based solutions for dietary supplement, food and beverage, ... announced that the October 1 presentation from ... available for on-demand viewing at ...   --> LINK: ...
(Date:10/7/2015)... Md. , Oct. 7, 2015   Intrexon ... synthetic biology, today announced it will hold an Investor ... on the afternoon of Thursday, November 12, 2015. Intrexon,s ... and other members of the Company,s management team ... including a focus on strategic initiatives, product pipeline, and ...
Breaking Biology Technology:
... was at a security conference and stayed at a hotel, ... claimed that they had implemented it so only those on ... ,I do not purchase wireless Internet service when Im at ... the seminar hosts office. Out of curiosity, on my second ...
... Commerce has announced that it is producing the Wisconsin ... Thursday, September 25, from 8:30 a.m. to 3:45 p.m. ... , ,Wisconsins medical device and technology cluster is ... state, said Department of Commerce (Commerce) Secretary Cory L. ...
... all things e-commerce will speak to cutting-edge Madisonians Thursday evening ... Club Majestic, 115 King Street in downtown Madison. , ,Nationally ... about how e-commerce is coming out of the weeds after ... Some companies are finally learning how to please consumers and ...
Cached Biology Technology:
(Date:9/10/2015)... LONDON , Sept. 10, 2015 Report ... thus far not quite delivered upon previous expectations of ... might be the breakthrough year in which wearables begin ... been expected. One of the main reasons is the ... disrupt not only the SmartWatches market, but the overall ...
(Date:9/8/2015)... , Sept. 8, 2015   TREW Marketing ... new survey, Smart Marketing for Engineers TM : ... engineering professionals reveals insightful findings about engineers, preferences for ... of content engineers most value and trust, and where ... Marketers targeting technical audiences grapple with how to best ...
(Date:9/2/2015)... Biometric technology ... system which uses identical human characteristic such as ... and finger print. Increasing number of terror attacks ... which provides high level of security. Traditional security ... are vulnerable to attacks. Furthermore, Biometric technology uses ...
Breaking Biology News(10 mins):
... adults living closer to a fast food restaurant had a ... away from fast food, according to researchers at The University ... particularly strong among those with a lower income. ... of Public Health indicates higher BMI associates with residential ...
... relationship between the heritable risk for schizophrenia and low ... associated with cognitive impairments that may cause functional disability. ... to the risk for developing schizophrenia. For example, reduced ... Also, these deficits may be present in healthy relatives ...
... hematopoiesis at sites outside the bone marrow in ... (LMU) in Munich now show that a specific type ... blood cells. Balanced hematopoiesis is essential for the ... takes place mainly in the liver and the spleen. ...
Cached Biology News:
Request Info...
... digests duplex DNA in a 3'-> 5' ... nick, producing stretches of single-stranded DNA. Under ... III proceeds at a uniform rate yielding ... of exonucleolytic excision of deoxyribonucleotides by Exonuclease ...
Mouse monoclonal [HL-37] to HLA DQ1 + HLA DQ3 ( Abpromise for all tested applications)....
Biology Products: